Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. classroom.jpg
    02 December '21

    POSTPONED - Advanced Course CTD module 3 - Quality section 2021

    Diegem

    Postponed due to COVID.

    This two-day course is intended to provide an in depth knowledge and understanding of the main principles and concepts of the Quality part of the Common Technical Document. 

  2. compliance (1).jpeg
    07 December '21

    Healixia conference: Medical Devices

    Online conference.

    This training course is intended for both manufacturers and distributors of medical devices/ in vitro medical devices and will address various questions/issues under the MDR/IVDR.

  3. Beneluxa_LS.jpeg
    14 December '21

    POSTPONED to spring 2022 - Healixia Conference: Deep Dive into BeNeLuxA

    Online and Diegem

    This event has been postponed to spring 2022 due to COVID.

    This is a hybrid event: you can attend live (Greenhouse Diegem) or online.

    Come and benchmark your current knowledge with actual insights and developments and receive practice advice, gain insight and discuss with peers about the challenges and opportunities.

    If you have questions about BeNeLuxA that you would like to see addressed, you can send them to info@healixia.be 

Show all meetings

News

  1. November 30, 2021

    Give your opinion on genetically modified vaccines to treat hepatitis B

    The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified vaccines ChAd155-hIi-HBV and MVA-HBV for the treatment of infections with the hepatitis B virus (HBV). The public consultation will run from 27 November 2021 to 27 December 2021.

    Source: FAMHP

    Read more

  2. November 25, 2021

    12th International Symposium of Drug Analysis - 32nd International Symposium on Pharmaceutical and Biomedical Analysis

    The Organising Committee of the International Symposium DA-PBA 2022 is pleased to announce its 2022 edition, which will take place in Mons, Belgium, from September 11-14, 2022. 

    This symposium will be a joint meeting of two distinguished series: the 12th International Symposium on Drug Analysis and the 32nd International Symposium on Pharmaceutical and Biomedical Analysis.

    Read more

  3. November 23, 2021

    Clinical Trials Regulation (CTR): specific webinar for small and medium-sized enterprises (SMEs) and academic sponsors

    In the context of the preparation of the implementation of the Clinical Trials Regulation (CTR), which will come into force on 31 January 2022, a specific webinar for SMEs and academic sponsors on key aspects of the CTR and the new processes via the Clinical Trials Information System (CTIS) for clinical trial application submissions will be organised on 29 November 2021.

    Source: FAMHP

    Read more

We thank our partners for their support. Click on the logos for more information:
 
digidyco_clinical esolutions_gr_web2.png QbD_logo_RGB_300dpi logo Hebias web.png Modis 440x320 nieuwsbrief.jpg
jsn_logo_jj_vert_color_rgb.jpg 20201210 AxTalis Logo MAx MA.jpg SCIENCETALENTS_LOGO_RGB_POS.png Brookwood Global-website.png